RxDoctor Payments Data

Matthew Hanna, MD

Anatomic Pathology & Clinical Pathology · Pittsburgh, PANPI 1336405349

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,099 of the $35,750 with a category attached, or 78.6%. 9 manufacturers reported payments, led by Astrazeneca UK Limited at 24.5% of the total. 2025 is the largest year on record at $27,138, more than ten times the $15 reported in 2019. Among anatomic pathology & clinical pathology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,750in general payments, 2019–2025

Across 25 payments — averaging $1430.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$9K
  • Hologic Sales And Service, LLC$8K
  • Gen-probe, Inc.$7K
  • Leica Microsystems Inc.$5K
  • Beckman Coulter, Inc.$3K
  • Roche Diagnostics Corporation$2K
  • plus $1K from 3 others
$25,000in research payments, 2019–2025

Across 1 payment — averaging $25,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gen-probe, Inc.$25K

What the payments were for

  • Consulting fees$28,09979%
  • Speaking & faculty fees$2,2026%
  • Travel & lodging$4,62513%
  • Food & beverage$8242%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,750 in reported general payments places this provider in the 95th percentile of 357 anatomic pathology & clinical pathology providers in Pennsylvania.

See all anatomic pathology & clinical pathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,675
Medicare patients
44
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →